Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In a recent study published in The Journal of the American Medical Association (JAMA), research from Oxford Trauma in conjunction with Warwick Clinical Trials Unit shows that intramedullary nail fixation provides better quality of life for patients in the 12 months following a fracture of the distal tibia and costs less than ‘locking’ plate fixation.

The shin bone (tibia) is the most commonly broken bone in the leg. Injuries in the lower part of the shin bone (distal tibia) nearly always require hospital admission and usually require surgery. Existing research suggested that modern ‘locking’ plate fixation and intramedullary nail fixation are the most common types of operation performed for this fracture. However, it was not clear which provides better outcomes for patients.

In this study, 321 adult patients having surgery for a fracture of the distal tibia were given either nail fixation or ‘locking’ plate fixation. Using the Disability Rating Index, patients reported their own outcomes at three, six and 12 months after their fracture. Further information was also collected on the patient’s quality of life, complications suffered and associated costs of the treatment.

The Disability Rating Index of both groups of patients improved in the months after their surgery, although patients were not back to normal even a year later. Patients who had nail fixation of their tibial fracture showed evidence of improvement at three months but there were no differences between the treatments after six months. There was also no difference in the number of complications suffered by each group, but further surgery was more common in the ‘locking’ plate group. The economic analysis showed nail fixation was cheaper than ‘locking’ plate fixation.

Commenting on the findings, Matthew Costa, Professor of Orthopaedic Trauma Surgery said: “The results of the trial will not only influence the type of surgery offered to patients but also help reduce costs to the NHS”.

Read the full report on The Journal of the American Medical Association:

Funding Body

hta_funded_logo.gif

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.